Zoladex
Total Payments
$364,369
Transactions
5,228
Doctors
2,985
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $171,669 | 2,607 | 1,815 |
| 2023 | $150,435 | 2,249 | 1,642 |
| 2022 | $38,894 | 271 | 207 |
| 2021 | $3,370 | 101 | 77 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $185,849 | 104 | 51.0% |
| Food and Beverage | $124,041 | 4,954 | 34.0% |
| Travel and Lodging | $26,700 | 107 | 7.3% |
| Space rental or facility fees (teaching hospital only) | $18,350 | 8 | 5.0% |
| Unspecified | $5,568 | 45 | 1.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,388 | 5 | 0.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,260 | 2 | 0.3% |
| Education | $213.50 | 3 | 0.1% |
Payments by Type
General
$358,801
5,183 transactions
Research
$5,568
45 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Phase II trial of androgen deprivation therapy (ADT) and pembrolizumab for advanced stage androgen receptor-positive salivary gland carcinoma: Big Ten Cancer Research Consortium | TerSera Therapeutics LLC | $5,568 | 0 |
Top Doctors Receiving Payments for Zoladex
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Hematology & Oncology | New York, NY | $37,736 | 24 |
| , M.D | Hematology & Oncology | Newport Beach, CA | $31,558 | 80 |
| Unknown | — | Chicago, IL | $24,115 | 63 |
| , M.D., PH.D | Internal Medicine | Los Angeles, CA | $9,794 | 16 |
| , MD | Medical Oncology | Dallas, TX | $9,217 | 8 |
| , M.D | Medical Oncology | Oak Brook, IL | $7,941 | 5 |
| , MD | Medical Oncology | San Antonio, TX | $5,524 | 7 |
| , M.D | Medical Oncology | San Antonio, TX | $5,372 | 6 |
| , MD | Internal Medicine | Avon, OH | $5,288 | 8 |
| , MD | Internal Medicine | Orlando, FL | $5,285 | 3 |
| , MD | Medical Oncology | Denver, CO | $4,837 | 5 |
| , M.D | Internal Medicine | Palo Alto, CA | $4,377 | 6 |
| , MD | Medical Oncology | La Jolla, CA | $3,781 | 2 |
| , MD | Hematology & Oncology | Northbrook, IL | $3,638 | 1 |
| , M.D | Hematology & Oncology | Rochester, MN | $3,421 | 1 |
| , M.D | Internal Medicine | Newton, MA | $3,385 | 6 |
| , M.D | Hematology & Oncology | Atlanta, GA | $3,376 | 6 |
| , M.D | Surgical Oncology | New York, NY | $3,234 | 4 |
| , MD | Student in an Organized Health Care Education/Training Program | New Orleans, LA | $3,212 | 6 |
| Nan Chen | Hematology & Oncology | Chicago, IL | $3,125 | 3 |
| , M.D | Hematology & Oncology | Westlake, OH | $3,039 | 5 |
| , MD | Internal Medicine | Houston, TX | $3,031 | 6 |
| , MD | Internal Medicine | Durham, NC | $2,965 | 5 |
| , MD | Obstetrics & Gynecology | Miami, FL | $2,873 | 6 |
| , MD | Medical Oncology | Gibsonia, PA | $2,807 | 5 |
Ad
Manufacturing Companies
- TerSera Therapeutics LLC $364,369
Product Information
- Type Drug
- Total Payments $364,369
- Total Doctors 2,985
- Transactions 5,228
About Zoladex
Zoladex is a drug associated with $364,369 in payments to 2,985 healthcare providers, recorded across 5,228 transactions in the CMS Open Payments database. The primary manufacturer is TerSera Therapeutics LLC.
Payment data is available from 2021 to 2024. In 2024, $171,669 was paid across 2,607 transactions to 1,815 doctors.
The most common payment nature for Zoladex is "Consulting Fee" ($185,849, 51.0% of total).
Zoladex is associated with 1 research study, including "Phase II trial of androgen deprivation therapy (ADT) and pembrolizumab for advanced stage androgen receptor-positive salivary gland carcinoma: Big Ten Cancer Research Consortium" ($5,568).